CFO of Creative Realities (CREX) receives 100,000 stock options grant

Rhea-AI Filing Summary

Creative Realities, Inc. granted Chief Financial Officer Tamra L. Koshewa options to purchase 100,000 shares of common stock on December 1, 2025. The options have a $2.89 exercise price and expire on December 1, 2035.

The grant vests over three years: 33,333 options on December 1, 2026, 33,333 on December 1, 2027, and 33,334 on December 1, 2028. After this grant, Koshewa beneficially owns 100,000 stock options directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koshewa Tamra L

(Last) (First) (Middle)

13100 MAGISTERIAL DRIVE

SUITE 102

(Street)

LOUISVILLE KY 40223

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CREATIVE REALITIES, INC. [ CREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$2.89	12/01/2025		A		100,000(1)		(1)	12/01/2035	Common Stock	100,000	$0	100,000(1)	D

Explanation of Responses:

1. Represents 100,000 options to purchase shares of Issuer's common stock, granted to Reporting Person subject to the terms of Issuer's 2023 Stock Incentive Plan, as amended, and the general form of Issuer's stock option agreement, with options vesting in three installments as follows: 33,333 vest on December 1, 2026, 33,333 vest on December 1, 2027 and 33,334 vest on December 1, 2028.

Remarks:

Exhibit 24.1 Power of Attorney filed with Form 3 on 01/28/2026 and incorporated herein by reference.

	/s/ Bradley Pederson, Attorney-in-Fact	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Creative Realities (CREX) disclose in this Form 4 filing?

Creative Realities reported a stock option grant to its Chief Financial Officer, Tamra L. Koshewa, for 100,000 options. These options are part of the company’s 2023 Stock Incentive Plan and vest in three annual installments starting December 1, 2026.

How many stock options did the CREX CFO receive in this transaction?

The Chief Financial Officer received 100,000 stock options. All 100,000 options were granted on December 1, 2025, and are exercisable for shares of Creative Realities common stock, subject to a multi-year vesting schedule under the 2023 Stock Incentive Plan.

What is the exercise price and term of the CREX CFO’s stock options?

The options have a $2.89 exercise price per share and expire on December 1, 2035. This means the CFO may purchase Creative Realities common stock at $2.89 per share if and when the options vest and are exercised before expiration.

How do the 100,000 CREX stock options granted to the CFO vest over time?

The 100,000 options vest in three installments: 33,333 options vest on December 1, 2026, another 33,333 on December 1, 2027, and the remaining 33,334 on December 1, 2028. Vesting requires continued service under the plan’s terms.

Under which plan were the CREX CFO’s stock options granted?

The options were granted under Creative Realities’ 2023 Stock Incentive Plan, as amended. They are also subject to the company’s standard stock option agreement, which governs vesting, exercisability, and other key terms for equity compensation awards.

Does the CREX CFO hold these 100,000 options directly or indirectly?

The Form 4 indicates that the 100,000 stock options are held directly by the CFO. There is no reference to an intermediary entity or trust, so beneficial ownership is reported in her own name as the Chief Financial Officer.